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0022-2836 © 2007 Elsevier Ltd. Open accesAntibiotic resistance is a widely spread phenomenon. One major mechan-
ism that underlies antibiotic resistance in bacteria is the active extrusion of
toxic compounds through the membrane-bound efflux pumps that are often
regulated at the transcriptional level. TtgR represses the transcription of
TtgABC, a key efflux pump in Pseudomonas putida, which is highly resistant
to antibiotics, solvents and toxic plant secondary products. Previously we
showed that TtgR is the only reported repressor that binds to different
classes of natural antimicrobial compounds, which are also extruded by the
efflux pump. We report here five high-resolution crystal structures of TtgR
from the solvent-tolerant strain DOT-T1E, including TtgR in complex with
common antibiotics and plant secondary metabolites. We provide structural
basis for the unique ligand binding properties of TtgR. We identify two
distinct and overlapping ligand binding sites; the first one is broader and
consists of mainly hydrophobic residues, whereas the second one is deeper
and contains more polar residues including Arg176, a unique residue
present in the DOT-T1E strain but not in other Pseudomonas strains.
Phloretin, a plant antimicrobial, can bind to both binding sites with distinct
binding affinities and stoichiometries. Results on ligand binding properties
of native and mutant TtgR proteins using isothermal titration calorimetry
confirm the binding affinities and stoichiometries, and suggest a potential
positive cooperativity between the two binding sites. The importance of
Arg176 in phloretin binding was further confirmed by the reduced ability of
phloretin in releasing the mutant TtgR from bound DNA compared to the
native protein. The results presented here highlight the importance and
versatility of regulatory systems in bacterial antibiotic resistance and open
up new avenues for novel antimicrobial development.© 2007 Elsevier Ltd. Open access under CC BY license. Keywords: crystal structure; multidrug binding; antibiotic resistance; ITC;
protein–ligand interaction*Corresponding authorIntroduction
Microorganisms are exposed to naturally occur-
ring deleterious chemicals in the environment, like
natural antibiotics produced by bacteria, fungi and
plants, or detergents such as bile salts, present in
the intestinal tract of higher animals. Human activ-
ity has led to the emergence of a great diversity of
noxious chemicals. Furthermore, some chemicals,
such as semi-synthetic antibiotics or biocides, have
been specifically developed to act as antimicrobial
agents. However, bacteria display resistance to theng author:
s under CC BY license. action of these toxic compounds through intrinsic
long-standing mechanisms that protect the bacterial
cells from continuous exposure to the toxic com-
pounds. The extrusion of toxic compounds by efflux
pumps is a major cell protective mechanism as it
provides an active outward transport of deleterious
compounds from the cytoplasmic membrane into
the external medium and reduces the concentration
of antimicrobials in the membranes and/or the
cytoplasm to sub-toxic levels.1,2 A number of studies
have shown that the expression of multidrug
resistance (MDR)1 efflux pumps is controlled by
transcriptional regulators with the same multidrug
recognition properties, such as BmrR of Bacillus
subtilis,3 EmrR of Escherichia coli,4 QacR of Staphy-
lococcus aureus5 and TtgR of Pseudomonas putida
830 Crystal Structures of TtgR in Complex with LigandsDOT-T1E.6,7 Studies on these transcriptional regu-
lators have shown that they act by directly binding
to a wide range of similar toxic compounds to that
exported by the membrane proteins whose expres-
sion they control, thereby facilitating the induction
of efflux pump genes in response to the presence of
diverse toxic substances.
P. putida is a non-pathogenic bacterium present in
water and soil that is able to colonize plant roots and
seeds.8,9 The DOT-T1E strain was isolated for its
particularly high resistance to toxic organic
solvents.10 Three efflux pumps, TtgABC, TtgDEF
and TtgGHI were found to be essential for this
resistance.11 Divergently transcribed from ttgABC
operon is ttgR, which encodes the corresponding
regulator. TtgR is a multidrug binding repressor that
negatively controls the transcription of the ttgABC
operon as well as its own expression. TtgR belongs
to the TetR family of proteins, which are character-
ized by a conserved DNA binding domain but
variable ligand binding domain. The TtgR-TtgABC
system has been shown to recognize and extrude
compounds that belong to different functional
classes including antibiotics, flavonoids and organic
solvents12–14; all of these compounds are toxic to the
bacterial cell. Flavonoids are present in the soil as
they are released from plant roots as a defensive
mechanism. Quercetin, a plant secondary metabo-
lite, was previously shown to possess antibacterial
activity15,16 through the inhibition of bacterial DNA
gyrases.17 However, the exposure of P. putida to
organic solvents is mainly due to human activity.
The toxicity of aromatic organic solvents is founded
in its capacity to dissolve into the membrane leading
to its damage.
The various compounds found to be relevant for
the TtgR-TtgABC system differ in structure and
toxic mechanism. We have previously shown that
these compounds act directly on TtgR, resulting in
increased tolerance of P. putida DOT-T1E to anti-
microbials.6,13 Here we provide the structural basis
for the binding of different types of natural ligands to
TtgR, including antibiotics (chloramphenicol and
tetracycline), and plant antimicrobials (phloretin,
quercetin and naringenin). Together these structures
presented here unveil the mechanism employed by
TtgR to recognize and bind to a wide range of
aromatic compounds.Results
Overall TtgR structure
Since TtgR crystals diffract poorly in the absence
of its ligands, we therefore focus here on TtgR
structures in complex with different ligands. The
structure of TtgR in complex with chloramphenicol
was determined using selenomethionine substituted
crystals and multiple-wavelength anomalous dif-
fraction (MAD) methods and all subsequent struc-
tures were determined by molecular replacementmethod using the TtgR/chloramphenicol structure
without the ligand as a starting model. A TtgR
monomer consists of nine alpha helices forming two
distinct domains (Figure 1(a)). The DNA binding
domain consists of α1–α3 (residues 1–53) while
the ligand-binding domain consists of α4–α9 (resi-
dues 54–210), with an angle of approximately 80°
between the two domains. The most unusual feature
of the TtgR structure is that there is a 65° inward
bending in the middle of α4 (residues 55–78, Figure
1(a)) compared to other family members. This bend
is at His70 (with a Phi Psi angle of ∼(−100°, 10°)
compared to ∼(−60°, −50°) for a typical α-helix) and
results in a relatively large portal formed between
α4 and α7 (residues 125–150, Figure 1(a)). This bend
also closes the channel at the top of the ligand
binding domain where the C-terminal half of α4
(residues 71–78), α5 (residues 85–103), and α7
(residues 125–150) form a helical bundle. α4 is not
involved in crystal contact or dimerization, hence
this bend is a distinct and native feature of TtgR. The
molecular surface of the TtgR dimer reveals a cleft
around the bend, ideal for ligand binding (Figure
1(b)). Closer examination of the cleft and the ligands
(see next section) reveals a large triangular ligand-
binding pocket, which is largely hydrophobic
(Figure 1(c)). One TtgR dimer is found within the
crystallographic asymmetric unit and no crystal-
lographic symmetry restraint is applied. Interest-
ingly, the individual monomers are almost identical
(rmsd Cα=0.5 Å) although some side-chain differ-
ences are observed within the ligand binding
pocket. α8 (residues 162–180), α9 (residues 191–
205), the loop connecting α6 and α7 (specifically
residues Glu118, Asp122), as well as the loop
connecting α1 and α2 (specifically residues Ala30,
Arg31) contribute to the dimer interface (Figure
1(d)). All TetR family members bind to DNA as a
homodimer utilizing the helix-turn-helix (HTH)
motif.18 The distance between the DNA recognition
helices (α3, residues 45 to 49) is 42 Å, significantly
larger than the 34 Å major groove distance of
B-DNA. Sequence alignment with TtgR close homo-
logues confirms the highly conserved nature of the
DNA binding domain with a relatively diverse
ligand-binding domain (Figure 2).
TtgR in complex with antibiotics
TtgR can recognize a wide range of molecules
including a number of antibiotics, flavonoids, as
well as aromatic solvents. The ligands differ in size
(with molecular mass ranging from 272 to 444 Da)
and shape, as well as their charge distributions
(Figure 3(a)). The only common feature of the
ligands is the presence of at least one aromatic ring.
To characterize the structural basis for antibiotic
binding to TtgR, we determined the crystal struc-
tures of TtgR in complex with tetracycline and
chloramphenicol, both at 2.7 Å resolution. The initial
2Fo–Fc map obtained using phases from the TtgR
model in the absence of ligands showed clear ligand
density (Supplementary Data Figure 1). Almost all
Figure 1. TtgR structures. (a) Ribbon diagram of TtgR dimer with helices labelled from N to C termini. Blue,
N-terminal; red, C-terminal. (b) Molecular surface of TtgR dimer calculated using PyMol clearly shows the cleft (arrow).
Red, oxygen; blue, nitrogen; white, carbon. (c) Ligand binding pocket of TtgR calculated using PyMol. (d) Closed-up view
of TtgR dimer interface, contributed by both the ligand binding domain and the DNA binding domain.
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domain are involved in tetracycline binding. More
specifically, the ligand binding pocket is formed
by residues from α4 (residues 55–78), α5 (residues
85–103), α6 (105–114), α7 (125–150), and α8 (162–
181) (Figures 1(a) and 3(b)). The ligand binding
pocket is relatively large, with a volume of
∼1500 Å3. Looking from the portal formed by α4
(55–78) and α7 (125–150) (Figures 1(a)–(c) and 3(b)),
the ligand binding pocket is an asymmetric pyramid
with α7 (125–150) and α8 (162–181) forming one
side of the wall, while the top halves of α4 (71–78)
and α5 (85–103) contribute to the other sides. The
lower half of α4 (55–69) together with α6 (105–114)
forms the bottomwall. The top of the pocket (far end
from the DNA binding domain) contains hydro-
phobic residues Ile141, Met89, and Met167, just as
the side walls do with Leu92, Leu93, Val96, Phe168,
and Val171. The bottom of the pocket however
consists of polar residues including Asn110, His114,
and Asp172 (Figure 3(b) and (c)). This is also
reflected by the charge distribution within thepocket (Figure 1(c)). The tetracycline molecule lies
almost parallel to the TtgR dimer axis with the
dimethylamino group located near the widest point
of the pocket, where α4 bends (Figure 1(a) and (c)).
Not surprisingly, the cyclic rings are surrounded by
the side wall hydrophobic residues including Leu92,
Leu93, Val96 (α4), Ile141 (α7), and Phe168 (α8) that
constitute the side wall (Figures 2 and 3(b)). The
hydroxyl groups of tetracycline interact with the
main chain N atoms and the side-chains of Asp172.
Asp172 also interacts with a number of hydroxyl
groups as well as the amino group through water
molecules. Interestingly, Asn110 is ideally posi-
tioned to coordinate the interaction with both the
dimethylamino and amino groups.
The structure of TtgR in complex with chloram-
phenicol was also determined at 2.7 Å resolution.
The TtgR structure is almost identical to that of TtgR
in complex with tetracycline. Chloramphenicol is
situated similarly to tetracycline and utilizes the
general hydrophobic environment of the side walls
with little specific interactions (Figure 3(c)).
Figure 2. Sequence alignment of TtgR from P. putida DOT-T1E with its close homologues. Residues involved in
effector binding are shaded in cyan for hydrophobic or yellow for polar residues. Secondary structure elements are
labelled. Completely conserved residues are shaded in red while highly conserved residues are coloured in red.
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Several flavonoids have antimicrobial properties,
and indeed, their ability to bind to TtgR and induce
the expression of the corresponding TtgABC efflux
pump was recently demonstrated.13 We obtained
structures of TtgR in complex with three flavonoids:
naringenin, quercetin, and phloretin and these
structures provide a detailed understanding of the
recognition of flavonoids by TtgR.TtgR in complex with quercetin and naringenin
Quercetin and naringenin have similar structures
consisting of a chromenone ring and a hydroxyphe-
nyl ring (Figure 3(a)). The two flavonoids differ by
additional hydroxyl groups in quercetin. Both
effectors bind at similar locations to the hydrophobic
binding site as tetracycline and chloramphenicol.
The chromenone rings are located near the top of the
binding pocket and are surrounded by Leu92, Leu93
(α5), Ile141 (α7) and Phe168 (α8) while the hydro-
xyphenyl ring is surrounded by Leu66 (α4) and
Val96 (α5), V171, and I175 (α8). A number of water
molecules also contribute to the interactions with theFigure 3. Detailed effector binding and interactions. (a) Ch
this study. (b) Tetracycline binding. (c) Chloramphenicol bindi
affinity phloretin binding. (g) Low affinity phloretin bindin
contributing to the binding sites are labelled and colour-coded
protein or yellow for ligand; S, orange; Cl, green. Interactio
molecules (red spheres) are represented by broken lines. Ligan
off for hydrogen bonds.chromenone ring. In the TtgR-naringenin complex,
the density for the hydroxyphenyl ring is poor,
reflecting the flexibility of the molecular structure,
even though the hydroxyphenyl ring is located at
the bottom of the pocket and can form hydrogen
bond with side-chains of Asn110 (Supplementary
Data Figure 1 and Figure 3(d)). The electron density
for quercetin is better defined (Supplementary Data
Figure 1). The extra hydroxyl groups in the chro-
menone ring interact with additional water mole-
cules. The hydroxyphenyl group is well defined,
forming interactions with side-chains of Asn110 and
His114 (Figure 3(e)). We propose that the increased
binding affinity of quercetin to TtgR (compared to
naringenin) is due to the additional interactions
formed between the extra hydroxyl groups of
quercetin (compared to naringenin) and TtgR as
well as water molecules.13 The increased affinity is
also reflected in the much better defined electron
density for quercetin compared to naringenin. The
quercetin and naringenin binding sites involve
exclusively residues of a single monomer, and it is
thus not surprising that one dimer of TtgR can bind
to two ligand molecules as observed in the
structures.emical structures of the effector molecules characterized in
ng. (d) Naringenin binding. (e) Quercetin binding. (f) High
g. Effector molecules are displayed as sticks. Residues
according to atomic properties. O, red; N, blue; C, white for
ns between ligands and TtgR residues as well as water
d binding sites were analysed using PyMol with a 3.6 Å cut
Figure 3 (legend on previous page)
833Crystal Structures of TtgR in Complex with Ligands
834 Crystal Structures of TtgR in Complex with LigandsIt is worthwhile to note that Asn110 at the bottom
of the ligand binding pocket interacts with both
positive (as in tetracycline) and negative (as in
narigenin and quercetin) charges using either OD1
or ND2 of its side-chains. Asn110 therefore plays an
important role in the ability of TtgR to bind to both
positively and negatively charged ligands.TtgR in complex with phloretin
Phloretin contains a 2,4,6-trihydroxyphenyl ring
connected to a 4-hydroxyphenyl ring. Contoured at
1σ level, the 2Fo–Fc electron density observed in one
of the binding pockets can easily accommodate two
phloretin molecules, one occupying a similar loca-
tion like that of tetracycline and quercetin, while the
second one lies horizontally at the bottom of the
binding pocket (Supplementary Data Figure 1). The
density for the horizontal molecule is better defined
than the vertical one, possibly indicating different
affinities and occupancies. The horizontal molecule,
which lies at the bottom and is buried deeply in the
binding pocket (Figure 3(f)), makes multiple inter-
actions between its hydroxyl groups and surround-
ing positively charged residues including His114,
Arg130, and Arg176′ (where prime indicates the
other monomer of the dimer) as well as a number of
water molecules (Figure 3(f)). The trihydroxyphenyl
also interacts with Asn110. A number of hydro-
phobic residues constitute the rest of the binding site
including Leu66, Leu113, Val134, and Phe168. Inter-
estingly, in the other monomer, only weak electron
density is accountable for the vertical binding site,
similar to the locations of tetracycline and other
ligands. We therefore term the horizontal bindingFigure 4. Isothermal titration calorimetry and EMSA stud
measurement of phloretin binding to native TtgR. Upper pane
phloretin into buffer (A) and into 22 μM dimeric TtgR (B).
Integrated and dilution corrected peak areas of the raw data. D
model of ORIGIN (Microcal). (b) ITC measurement of phloreti
bound TtgR for native (grey bars) and R176G mutant (whitesite to be the high affinity specific site and the vertical
binding site to be the low affinity general binding
site. Detailed comparison between the two TtgR
monomers suggests that utilizing Arg176′ of the
adjacent monomer in phloretin binding partially
blocks the phloretin binding site in the adjacent
monomer. Our observation suggests that only one
phloretin molecule can bind to the specific site per
TtgR dimer while additional phloretin molecules
could bind to the general binding site, one in each
TtgR monomer.
The 1+2 effector molecules per TtgR dimer
stoichiometry is very unusual. To verify our inter-
pretation, the binding of phloretin to a concentrated
solution of TtgR was studied by isothermal titration
calorimetry (ITC), which is illustrated in Figure 4.
The binding curve is biphasic and a satisfactory
curve fit was obtained with the “two independent
sites” algorithm of the ORIGIN software (Microcal).
An initial high affinity event (KA=(2.1±0.4)×107
M−1, ΔH=−15.1(±0.1) kcal/mol) can be distin-
guished from a second event characterized by a
lower affinity (KA=(4.6±1.1)×10
5 M−1) and a less
favorable enthalpy change (ΔH=−1.83(±0.13) kcal/
mol). Most interestingly the n values associated
with the first and second event were 1.02±0.2 and
2.06±0.06, respectively. This implies that one effec-
tor molecule binds with high affinity to the TtgR
dimer (first event) followed by the binding of
another two effector molecules to the dimer (second
event). Therefore, the binding of the latter two
phloretin molecules appears to occur in a unique
thermodynamic event, which is further supported
by the fact that the ligand is similarly positioned in
both general binding sites in both monomersies of effector binding to native and mutant TtgR. (a) ITC
l: Heat changes for the injection of 1.6 μl aliquots of 2 mM
For clarity data were off-set on the y-axis. Lower panel:
ata were fitted with the “two-independent binding sites”
n binding to TtgRR176G. (c) EMSA measurements of DNA-
bars) in the presence of different effectors.
835Crystal Structures of TtgR in Complex with Ligands(Supplementary Data Figure 2(a) and (b)). In total,
three phloretin molecules are necessary to saturate
the TtgR dimer and data confirm our interpretation
of the electron density.
Mutagenesis studies to confirm the binding sites
Arg176 plays an important role in phloretin
binding at the high affinity site. It also contributes
to the one ligand molecule per TtgR dimer binding
stoichiometry for the first binding event (Figures 3(f)
and 4(a)). Interestingly, in P. putida KT2440 strain,
which has a lower tolerance to toxic chemicals, this
same position (residue 176) has a Gly instead of Arg
(Figure 2). We therefore mutated Arg176 to Gly and
investigated the binding of phloretin using ITC. The
data can be fitted well with a one-site binding model
with a 2:1 stoichiometry (two effector molecules per
TtgR dimer) and the binding affinity is characterized
by aKA of (1.09±0.06)×10
5M−1 (Table 1). These data
are similar to that of the low affinity site (two effector
molecules per TtgR dimer and KA of (4.6±1.1)×10
5
M−1, Figure 4(a) and (b)). Overall, this observation is
consistent with the interpretation that Arg176
mainly contributes to the high affinity site and one
effector molecule per TtgR dimer stoichiometry of
the high affinity site.
To verify that R176G indeed reduces the affinity of
the high affinity site, we determined the crystal
structure of TtgRR176G in complex with phloretin.
Initial 2Fo–Fc electron density maps using TtgR
without any ligands as a model show densities for
phloretin in the lower affinity binding site (Supple-
mentary Data Figure 2(c) and (d)), but not in the
high affinity site. These data confirm that Arg176
contributes to the high affinity site, and the mutation
of Arg176 to Gly significantly affects the high af-
finity site, while much less the lower affinity site.
TtgRR176G binds to naringenin similarly to wild-type
TtgR (Table 1), confirming that Arg176 contributes
mostly to the high affinity site.
To investigate the physiological effects of R176G
mutant, electrophoreticmobility shift assays (EMSA)
were used to measure the amount of DNA-bound
TtgR after exposure to different effector molecules
(cloramphenicol, naringenin and phloretin). These
experiments show that TtgRR176G does not release
from its operator site in the presence of phloretin as
efficiently as the wild-type TtgR (Figure 4(c)),
whereas in the presence of chloramphenicol andTable 1. Thermodynamic parameters derived from the micro
different effector molecules
Effector Proteins KA (M
−1) KD (μM)
Phloretin TtgRa (2.1±0.4)×107 0.05±0.01
(4.6±1.1)×105 2.2±0.5
TtgRR176G (1.09±0.06)×105 9.2±0.5
Naringenin TtgR (5.5±0.1)×104 18±0.3
TtgRR176G (3.5±0.3)×104 28.9±2.5
a Analysis with the “two binding-sites model” MicroCal version of
site model”.naringenin, TtgRR176G behaved similarly to the
wild-type. Therefore, the mutation of R176 to G
affects not only the binding of phloretin by TtgR
but also its response to this flavonoid, since the
release of TtgRR176G from its operator site is
reduced.Discussion
Two distinct binding sites contribute to the
versatile binding property of TtgR
Our work has identified two distinct binding sites
within the large pocket in TtgR (Figure 1(c)), which
contributes to the triangular shape of the binding
pocket. The binding pocket is mainly hydrophobic,
thus explaining its ability to bind to versatile
aromatic ligands. The binding sites are not sepa-
rated by the functionality of the compounds, being
antibiotic or flavonoids, but by their chemical prop-
erty, such as stereochemistry, conformation, and
size. Phloretin, which has the highest binding af-
finity among the known ligands to TtgR,13 can bind
to both sites with a total of three phloretin molecules
observed within the TtgR dimer structure, one at the
high affinity binding site, two at the low affinity
binding sites. The phloretin in the high affinity
binding site is located at the bottom of the binding
pocket, lying horizontally, utilizing Arg176′ from
the adjacent monomer to neutralize one of its
hydroxyl groups. This in turn prevents the binding
of phloretin to the high affinity site in the second
monomer, explaining the 1:2 stoichiometry between
phloretin and TtgR for this binding site. The high
affinity site is smaller and significantly more buried
(Figure 1(c)) and involves a number of specific
interactions that contribute to the increased binding
affinity (Figure 3(f)). Although naringenin has a
similar size to phloretin, the hydrophobic environ-
ment provided by Val134 and Phe168 is not
compatible with the charges of the naringenin
chromenone ring.
In the case of quercetin, naringenin, tetracycline,
chloramphenicol, as well as additional phloretin
molecules, binding occurs vertically in the binding
pocket with little specific interactions. This binding
site is broader, more exposed, and contains less
specific interactions (Figure 1(c)). We therefore termcalorimetric titration of wild-type and mutant TtgR with
ΔG(kcal/mol) ΔH(kcal/mol) TΔS(kcal/mol)
−10.2±0.1 −15.1±0.1 −4.9±0.2
−7.8±0.2 −1.8±0.2 6.0±0.2
−7.0±0.1 −21.6±0.5 −14.6±0.2
−6.6±0.1 −10.8±0.1 −4.2±0.1
−6.3±0.6 −24.9±3.5 −18.6±1.8
ORIGIN. All the other data were analysed with the “one binding-
836 Crystal Structures of TtgR in Complex with Ligandsthis site the general binding site, which most
probably contributes to the versatility of TtgR's
ligand binding property. However, these two sites
are not completely separated. In fact, the bottom of
the low affinity site overlaps with the high affinity
site of phloretin, sharing several residues such as
Leu66, His67, and Phe168.
R176G mutant TtgR binds to phloretin with
reduced affinity and 1:1 stoichiometry (1 phloretin
molecule per monomer), only to the low affinity
site. Therefore, mutating this residue significantly
affects the high affinity site and therefore the low
affinity site becomes the dominant binding site.
This is consistent with the observation that Arg176
mainly contributes to the high affinity site. How-
ever, TtgRR176G binds to phloretin with a reduced
affinity in the low affinity site, suggesting a potential
positive cooperativity between the two sites in TtgR
for phloretin binding. TtgRR176G structure largely
superposes well with wild-type TtgR structure.
However, there are a number of side-chain confor-
mational changes within the binding pocket, when
TtgR and TtgRR176G structures are compared, in-
cluding Arg130, His67, and Phe168 (Supplementary
Data Figure 2(e)). Residues 67 and 168 also con-
tribute to the lower affinity site, providing possible
explanations for the cooperative property of the two
sites in phloretin binding.
TtgR displays unique binding sites compared to
other TetR family members
Structurally TtgR is a member of the TetR family
of transcriptional repressors. The TetR protein
family is characterized by a conserved HTH DNA
binding domain and binds to DNA as a homo-
dimer.18 However, the sequence conservation in the
ligand binding domain is poor and the ligands that
they recognize are diverse. TetR, the tetracycline
repressor from which the TetR protein family
derives its name, binds to tetracycline exclusivelyFigure 5. Comparison of TtgR with TetR and QacR ligan
Tetracycline is shown as sticks while TetR is shown as ribbons c
in a significantly different manner from TetR. (c) QacR bindswith high affinity (nM affinity). The tetracycline
binding site in TetR is exclusively confined within
one monomer and Mg2+ is chelated between hy-
droxyl groups of tetracycline and His110 of TetR.19
Tetracycline fits tightly into a well-defined binding
pocket of TetR with its amino groups at the
innermost point of the pocket and the cyclic ring
on the outer side19 (Figure 5(a)). On the other hand,
in TtgR, tetracycline binds vertically in the general
binding site of TtgR, with its amide groups at the
bottom of the pocket and the cyclic rings near the
top of the pocket with little specific interactions,
explaining its micromolar affinity to tetracycline
(Figures 1(c), 3(b) and 5).
The TtgR structure displays strong similarity with
that of QacR (1QVU), a multi-drug binding protein
from S. aureus, in terms of secondary structures
(Figure 5(b) and (c)) although the ternary structure is
different (rmsd Cα 3.6 Å for the whole protein, rmsd
Cα 0.9 Å for DNA binding domain, and 3.1 Å for
ligand binding domain). QacR binds to a variety of
positively charged ligands with micromolar affi-
nities and a number of negatively charged residues
within the pocket are responsible for this speci-
ficity.20,21 In TtgR, a general hydrophobic environ-
ment is provided in the binding pocket though a
number of polar residues, including His114 and
Asn110 are also involved in binding, explaining the
presence of predominantly negative charges in TtgR
ligands. In QacR, multiple binding sites are also
identified though the binding pocket of TtgR is even
broader than that of QacR (∼1500 Å3 compared to
1100 Å3).21 Furthermore, all the ligands bind to
QacR with a 1:2 stoichiometry (one ligand per QacR
dimer)21 while either 1:2 or 1:1 stoichiometry has
been observed for TtgR. In QacR, the ligand entry
portal is proposed to be near the dimer interface.
Therefore binding to one monomer is proposed to
obstruct the ligand entry to the adjacent monomer.
However, in TtgR the most possible ligand entry is
through the large portal formed at the bend of α4d binding sites. (a) TetR binding to tetracycline (2TCT).
oloured fromN to C termini. (b) Tetracycline binds to TtgR
to two drugs simultaneously (1QVU).
837Crystal Structures of TtgR in Complex with Ligands(Figure 1(b)), well away from the dimer interface
though some ligands utilize residues from the
adjacent monomer.
Implications in multidrug resistance
The data presented here explain how TtgR could
recognize a wide range of antibiotics and plant sec-
ondary metabolites. Contrary to many other studies
in multidrug resistance phenomena where many
effectors characterized were laboratory reagents,
the effectors studied here all have a physiological
relevance. We identify two distinct binding sites
within the protein. It is important to note that almost
all the residues are conserved among most Pseudo-
monas species (Figure 2) including its close homo-
logues P. fluorescens and P. syringae. The hydrophobic
residues lining the side walls in the general binding
site are also conserved among E. coli, Neisseria me-
ningitidis, as well as P. aeruginosa, suggesting that
the general binding site is conserved among these
species.
Interestingly, P. putida DOT-T1E, one of the most
resilient bacterial strains to toxic chemicals, has Arg
instead of Gly or Tyr at position 176. Our structural
data identify Arg176 as a crucial residue for the high
affinity site. ITC data on TtgRR176G protein confirm
that changes at this residue result in reduced
binding affinity to phloretin and possibly other
effectors that utilize this binding site. EMSA results
confirm that this reduced affinity of phloretin results
in a reduced ability to release TtgRR176G from bound
DNA. These results highlight the importance of the
regulatory system (not necessarily the efflux pumps
themselves) in altering the ability of antibiotic
resistance and open up avenues for developing
effective antibiotics.Materials and Methods
Protein expression, purification, and crystallisation
TtgR proteins were expressed and purified as des-
cribed.6,13,22 In short, ttgR cloned into pET29a+ plasmid
was over-expressed in E. coli B834(DE3) cells (Novagen)
after induction with 1 mM IPTG, when A600 nm reached 0.8.
Proteins were expressed at 22 °C for 3 h. Cells were
harvested by centrifugation and resuspended in 20 ml of
Heparin A buffer (10 mM Tris-HCl (pH 6.4), 50 mM NaCl,
5% (v/v) glycerol. Cells were lysed by sonication and the
suspension was centrifuged at 12,000g for 30 min. The
protein was then purified using a HiTrap Heparin HP
column followed by gel filtration using a Superdex 200
HiLoad. The Se-Met TtgR was over-expressed in methio-
nine auxotroph B834 cells grown in M9 minimal media
supplemented with selenomethionine. Similar purification
strategies were followed. Both TtgR and Se-Met TtgR
were concentrated to 14 mg/ml. Crystals were grown
using the sitting-drop vapor diffusion method in 0.2 M
MgCl2, 0.1 M Bis-Tris (pH 6.5), 25% (v/v) PEG3350. The
TtgR in complex with tetracycline was crystallized by
mixing TtgR with tetracycline in 1:5 molar ratios and
crystallized in 0.2 M MgCl2, 0.1 M Bis-Tris (pH 6.5), 10%PEG3350. TtgR in complex with chloramphenicol, phlor-
etin, naringenin, and quercetin were crystallized using the
same protocol and in similar conditions.
Crystallographic data collection and structural
determination
All crystals were soaked in crystallization buffer sup-
plemented with 20% (v/v) glycerol as cryo-protectant
before being frozen in liquid nitrogen. Datasets were
collected under cryogenic conditions. All the datasets
were collected at beamline ID29 at the European
Synchrotron Radiation Facility or beamline 10.1 at the
Daresbury Synchrotron Radiation Source. Data were
processed using HKL2000 and scalepack23 or Mosflm.24
All the complexes crystallized in similar conditions and
are in space group P21212 with unit cell dimensions of
46, 231, and 44 Å. The structure of TtgR in complex with
chloramphenicol was determined using selenomethio-
nine substituted crystals and MAD methods25 using the
selenium peak, inflection, and close remote energies.
Five selenium sites were located and refined using
SOLVE.26 Density modification and phase extension
were carried out in RESOLVE.26 Subsequent model
building/rebuilding were performed in the programs
O27 and COOT.28 Model refinement was done using
CNS29 by setting aside 10% of the observed reflection
data for cross-validation. Subsequently, all the other
structures were determined using the molecular replace-
ment method implemented in the program PHASER30
and refined using CNS.29 All the structures were refined
to 2.7–2.3 Å resolution. More than 88% residues are
within the favoured regions of the Ramachandran plot
and no residues are within disallowed regions. Clear
electron densities were observed for most residues
between positions 10 and 210 in all the structures except
a number of loop regions (residues 75–81, 148–162)
where weak electron densities were found, probably
reflecting the flexibility and partial disorder of these
regions, which contribute partially to the relatively high
Rfree values (Table 2). Significant extra electron densities
were observed in a large pocket in the 2Fo–Fc maps
using TtgR without ligand as a model (Supplementary
Data Figure 1). We attribute these densities with distinct
shapes to the different ligand molecules bound. Solvent
or small molecules in the crystallization buffers were
ruled out due to the distinct shape and relatively large
size of these densities. Ligand molecules were modeled
in after many refinement cycles of TtgR alone guided by
the crystallographic Rfree. In general, adding ligand
molecules resulted in a 0.3–0.5% reduction in Rfree. The
geometries of ligand molecules were adjusted in COOT
using both real space fitting and manual adjustment to
best fit into the electron density and satisfy chemical
constraints. The final simulated annealing omit maps
confirm the positioning of the ligand molecules (Supple-
mentary Data Figure 1), and the quality of the density is
in accord with the relatively low affinity of the ligands
(KD of ∼10–50 μM). The data quality and refinement
statistics are summarized in Table 2.
Isothermal titration calorimetry (ITC)
Measurements were performed on a VP-Microcalori-
meter (MicroCal, Northampton, MA, USA) at 30 °C. The
protein was thoroughly dialysed against 25 mM Pipes
(pH 7.0), 250 mM NaCl, 5% (v/v) glycerol, 10 mM
magnesium acetate, 10 mM KCl, 0.1 mM EDTA, 1 mM
Table 2. Data collection and refinement statistics
Semet
Phloretin Quercetin Naringenin Tetracycline Chloramphenicol Peak Inflection Remote
Data collection
Space group P21212 P21212 P21212 P21212 P21212 P21212
Cell dimensions
a, b, c (Å) 47.2, 230.6,
43.9
46.7, 231.9,
44.3
46.6, 230.7,
44.0
46.2, 232.4,
44.0
46.5, 230.8,
44.0
46.7, 231.8,
44.2
46.7, 231.8,
44.2
46.7, 231.8,
44.2
α, β, γ (°) 90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
Resolution (Å) 50–2.5 50–2.4 50–2.3 50–2.7 50–2.7 50–2.96 50–3.0 50–3.0
Rsym or Rmerge 6.5 (39.8) 9.4 (38.2) 5.4 (43.8) 9.6 (37.6) 9.9 (69.3) 7.0 (13) 5.6 (11) 6.4 (12)
I/sI 36.1 (6.2) 5.3 (1.5) 7.2 (1.7) 32.0 (7.9) 38.1 (5.3) 21.3(7.3) 23.5 (6.9) 22.5 (6.6)
Completeness (%) 92.9 (94.6) 96.6 (92.6) 90.5 (63.0) 92.9 (98.9) 96.2 (95.3) 93.43 (80.1) 94.86 (85.8) 94.6 (85.2)
Redundancy 6.6 5.0 5.7 5.3 8.6 5.9 5.7 5.6
Wavelength (Å) 0.9756 0.9756 0.9330 0.9756 0.9765 0.9802 0.9805 0.9763
Wilson B-factor (Å2) 56.1 37.4 43.7 44.5 46.1
Refinement
Resolution (Å) 50–2.5 50–2.4 50–2.3 50–2.7 50–2.7
No. reflections 15,174 16,721 18,368 12,692 12,226
Rwork/Rfree 24.5/29.4 23.7/29.5 24.3/29.1 23.1/29.4 23.2/29.6
No. atoms 3432 3458 3283 3329 3322
Protein 3207 3200 3122 3140 3169
Ligand/ion 60 44 40 32 40
Water 165 214 121 157 113
B-factors (Å2)
Overall 60.0 51.2 49.7 50.5 65.2
Protein 61.2 51.3 49.1 49.8 66.2
Ligand/ion 68.2 58.0 63.2 96.0 94.4
Water 32.6 49.4 60.5 54.5 26.7
r.m.s deviations
Bond lengths (Å) 0015 0.014 0.0230 0.016 0.016
Bond angles (°) 1.634 1.563 1.445 1.645 1.484
Ramachandran plot (%)
Favoured 91.0 91.0 89.2 89.7 91.0
Allowed 9.0 9.0 10.5 10.3 9.0
Generous 0.0 0.0 0.3 0.0 0.0
Dissallowed 0.0 0.0 0.0 0.0 0.0
838 Crystal Structures of TtgR in Complex with LigandsDTT buffer. The protein concentration was determined
using the Bradford assay. Stock solutions of phloretin,
chloramphenicol and naringenin at a concentration of
500 mM were prepared in dimethyl sulfoxide and the
solutions were subsequently diluted with dialysis buffer
to final concentrations of 1 mM (naringenin) or 2 mM
(phloretin). The corresponding amount of dimethyl
sulfoxide was added to the protein sample. Each
titration involved injections of effectors into protein
solution. Identical experimental conditions were used to
analyse wild-type as well as mutant proteins. The mean
enthalpies measured from injection of the ligands into
the buffer were subtracted from raw titration data prior
to data analysis with ORIGIN software (MicroCal).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays were carried out as
described.6 The DNA probe was a 189 bp fragment
containing the ttgABC-ttgR intergenic region obtained
from P. putida DOT-T1E chromosomal DNA by PCR. 1 nM
of the radiolabelled probe (∼10,000 cpm) was incubated
with 0.75 μMpurified TtgR in 10 μl of DNA binding buffer
(10 mM Tris-HCl (pH 7.0), 250 mM NaCl, 10 mM
magnesium acetate, 10 mM KCl, 5% glycerol, 0.1 mM
EDTA, 1 mM DTT) supplemented with 20 μg/ml poly(dI-
dC) and 200 μg/ml bovine serum albumin. Effectors(prepared in DMSO) were added to the binding reaction at
a final concentration of 1 mM. Reactions were incubated
for 10 min at 30 °C and samples were run on 4.5% (w/v)
non-denaturing polyacrylamide gels (Bio-Rad Mini-Pro-
tean II) for 2 h at 50 Vat room temperature in Tris glycine
buffer (25 mM Tris-HCl (pH 8.0), 200 mM glycine). The
resulting gels were analysed using a Personal FX equip-
ment and QuantityOne software (Bio-Rad).
Structural analysis and molecular graphics
TtgR structures (full-length, DNA binding domain, and
ligand binding domain) were submitted to DALI server31
to obtain structural homologues. Root-mean-square
deviation (rmsd) of Cα atoms between TtgR and QacR
were obtained from the DALI server. Distance calculations
were performed using the CCP4 program LSQKAB.32
Cavity calculations were performed using CASTp.33
Sequence alignment and annotations were performed
using ClustalW34 and Espript.35 All the Figures were
produced using PyMol.36Protein Data Bank accession codes
All the structural data have been deposited to the RCSB
Protein Data Bank through European Bioinformatics
839Crystal Structures of TtgR in Complex with LigandsInstitute and are available under accession codes 2UXP,
2UXO, 2UXI, 2UXU, 2UXH.Acknowledgements
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